The latest example of this trend is Merck KGaA’s impending all-cash acquisition of SpringWorks Therapeutics, valued around ...

For many years, the pharmaceutical business concentrated mostly on blockbuster medications, which are cures for common ...

Notably, there has been speculation about a potential acquisition of SpringWorks by Merck (NSE:PROR) KGaA. Analysts view this potential acquisition as strategically sound for several reasons ...

Notably, there has been speculation about a potential acquisition of SpringWorks by Merck (NSE:PROR) KGaA. Analysts view this potential acquisition as strategically sound for several reasons: 1. There ...

German chemical and pharma group Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming. Merck said in a ...

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...

SpringWorks Therapeutics (SWTX) and Jennifer Fisher are collaborating to increase understanding of desmoid tumors as well as to encourage ...

Experts noted that rapid and extreme weight loss can introduce unique risks, such as a weakened immune system and malnourishment, as well as potentially too much muscle loss. They’re also concerned ...